Anhui Anke Biotechnology (Group) Co., Ltd. (SHE:300009)
China flag China · Delayed Price · Currency is CNY
8.86
+0.07 (0.80%)
May 8, 2026, 3:04 PM CST

SHE:300009 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Operating Revenue
2,5562,6432,5332,8612,3272,160
Other Revenue
3.193.192.654.574.188.5
2,5592,6472,5362,8662,3312,169
Revenue Growth (YoY)
2.02%4.36%-11.51%22.94%7.48%27.47%
Cost of Revenue
647.97660.63581.16626.15513.47436.15
Gross Profit
1,9121,9861,9552,2401,8181,733
Selling, General & Admin
919.91947.93986.631,035871.18942.68
Research & Development
221.58219.45201.29254.68166.01166.54
Other Operating Expenses
17.829.80.6817.2119.3219.47
Operating Expenses
1,1651,1861,1961,3271,0621,133
Operating Income
746.98800.39759.09912.92755.7599.3
Interest Expense
-1.47-1.93-2.4-1.87-1.52-1.62
Interest & Investment Income
15.7221.6820.425.899.6111.52
Currency Exchange Gain (Loss)
-2.97-2.970.080.860.063.92
Other Non Operating Income (Expenses)
-0.48-3.36-2.79-1.1126.47-12.29
EBT Excluding Unusual Items
757.77813.81774.4916.69790.32600.83
Impairment of Goodwill
------322.6
Gain (Loss) on Sale of Investments
7.021.8810.52-15.4419.86-2.24
Gain (Loss) on Sale of Assets
5.956.31.090.12-1.21.68
Asset Writedown
-0.38-0.38-0.15-1.49-4.47-0.84
Other Unusual Items
12.0611.5517.1620.0529.3418.28
Pretax Income
782.43833.16803.02919.93833.85295.12
Income Tax Expense
76.2485.8287.1861.3496.1991.73
Earnings From Continuing Operations
706.19747.34715.84858.59737.66203.39
Minority Interest in Earnings
-12.41-12.15-8.89-11.36-34.43.24
Net Income
693.78735.19706.95847.23703.26206.63
Net Income to Common
693.78735.19706.95847.23703.26206.63
Net Income Growth
-0.63%4.00%-16.56%20.47%240.35%-42.44%
Shares Outstanding (Basic)
1,6541,6711,6831,6741,6351,589
Shares Outstanding (Diluted)
1,6541,6711,6831,6741,6351,589
Shares Change (YoY)
-2.66%-0.73%0.57%2.34%2.90%-2.58%
EPS (Basic)
0.420.440.420.510.430.13
EPS (Diluted)
0.420.440.420.510.430.13
EPS Growth
2.08%4.76%-17.03%17.72%230.77%-40.91%
Free Cash Flow
679.03736.33568.15757.64224.64460.94
Free Cash Flow Per Share
0.410.440.340.450.140.29
Dividend Per Share
0.2500.2500.2500.2500.2500.200
Dividend Growth
----25.00%19.98%
Gross Margin
74.68%75.04%77.08%78.15%77.97%79.89%
Operating Margin
29.18%30.24%29.93%31.86%32.42%27.63%
Profit Margin
27.11%27.78%27.88%29.56%30.17%9.53%
Free Cash Flow Margin
26.53%27.82%22.40%26.44%9.64%21.25%
EBITDA
862.68915.31870.9993.44836.21676.71
EBITDA Margin
33.70%34.59%34.34%34.67%35.87%31.20%
D&A For EBITDA
115.71114.93111.880.5280.577.41
EBIT
746.98800.39759.09912.92755.7599.3
EBIT Margin
29.18%30.24%29.93%31.86%32.42%27.63%
Effective Tax Rate
9.74%10.30%10.86%6.67%11.54%31.08%
Revenue as Reported
2,5592,6472,5362,8662,3312,169
Advertising Expenses
-57.5233.4411.128.249.96
Source: S&P Global Market Intelligence. Standard template. Financial Sources.